Showing results (391-400 of 513) with videos related to
Sort By:
Pageof 52
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2010
One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typingDavid Valcárcel, Jorge Sierra, Tao Wang, et al.Leukemia|November 20, 2009
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA allelesB E Shaw, N P Mayor, N H Russell, et al.Bone Marrow Transplantation|August 30, 2008
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplantB E Shaw, G J Mufti, S Mackinnon, et al.Haematologica|January 26, 2013
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trialDavid I Marks, Anthony V Moorman, Lucy Chilton, et al.Science Translational Medicine|November 17, 2017
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulationAntonio Galleu, Yanira Riffo-Vasquez, Cristina Trento, et al.Bone Marrow Transplantation|August 24, 2004
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplantM Eapen, S A Giralt, M M Horowitz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2010
Second unrelated donor hematopoietic cell transplantation for primary graft failureJeffrey Schriber, Manza-A Agovi, Vincent Ho, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphomaMarcel P Devetten, Parameswaran N Hari, Jeanette Carreras, et al.Bone Marrow Transplantation|December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantationG Akpek, M C Pasquini, B Logan, et al.Blood Advances|September 3, 2021
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trialRachel J Mitchell, Amy A Kirkwood, Emilio Barretta, et al.Pageof 52